EUVIMEDEUVIMED entdecken
Crossref

Long-term Responders to Nanoparticle Albumin-bound Paclitaxel Following Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer

Koki Nakashima, Yukihiro Umeda, Yoshiki Demura, Koji Yamaoka, Tomoaki Sonoda, Toshihiko Tada, Yuko Waseda, Tamotsu Ishizuka

Anticancer Research · 2024

DOI: 10.21873/anticanres.17335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Koki Nakashima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; kouk0527@yahoo.co.jp. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Immune Checkpoint Inhibitors, Lung Neoplasms, Albumin-Bound Paclitaxel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungImmune Checkpoint InhibitorsLung NeoplasmsAlbumin-Bound PaclitaxelHumansFemaleMaleAgedMiddle AgedNanoparticlesRetrospective StudiesAged, 80 and overAlbuminsTreatment OutcomePaclitaxelProgression-Free SurvivalAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

Non-small cell lung cancer (NSCLC)immune checkpoint inhibitor (ICI)nab-PTXnanoparticle albumin-bound paclitaxelsubsequent treatment

Substanzen

Immune Checkpoint InhibitorsAlbumin-Bound Paclitaxel130-nm albumin-bound paclitaxelAlbuminsPaclitaxel

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; kouk0527@yahoo.co.jp.
  • Department of Respiratory Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Department of Respiratory Medicine, Japanese Red Cross Fukui Hospital, Fukui, Japan.

Zitieren

APA

Nakashima, K., Umeda, Y., Demura, Y., Yamaoka, K., Sonoda, T., Tada, T., Waseda, Y., & Ishizuka, T. (2024). Long-term Responders to Nanoparticle Albumin-bound Paclitaxel Following Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17335

Vancouver

Nakashima K, Umeda Y, Demura Y, Yamaoka K, Sonoda T, Tada T, et al. Long-term Responders to Nanoparticle Albumin-bound Paclitaxel Following Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.17335

BibTeX
@article{Nakashima2024,
  author = {Nakashima, Koki and Umeda, Yukihiro and Demura, Yoshiki and Yamaoka, Koji and Sonoda, Tomoaki and Tada, Toshihiko and Waseda, Yuko and Ishizuka, Tamotsu},
  title = {Long-term Responders to Nanoparticle Albumin-bound Paclitaxel Following Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17335}
}
Kostenlos starten →